The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the ClinicalTrials.gov link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.
You can also contact the CTN coordinating centre for additional information: ECFS-CTN@uzleuven.be
| Study Title | A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects 12 Months of Age and Older |
|---|---|
| Study Drug | Elexacaftor/Tezacaftor/Ivacaftor |
| Type of Study Drug | CFTR Modulation |
| Study Phase | 3 |
| Study Sponsor | Vertex |
Link in registry(ies) | https://clinicaltrials.gov/study/NCT06460506 |
| Participating ECFS-CTN sites | Please contact ecfs-ctn@uzleuven.be for most recent sitelist |
| Age | Pediatric patients |